Comments President and Chief Executive Officer
Post# of 148154
(Total Views: 424)
Posted On: 02/23/2021 9:08:17 AM
Comments
President and Chief Executive Officer CytoDyn Inc.
1111 Main Street, Suite 660 Vancouver, Washington 98660
Re: CytoDyn Inc.
Registration Statement on Form S-3 Filed January 15, 2021
File No. 333-252154
Dear Dr. Pourhassan:
January 21, 2021
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
cc: Arian Colachis
Sincerely,
Division of Corporation Finance
President and Chief Executive Officer CytoDyn Inc.
1111 Main Street, Suite 660 Vancouver, Washington 98660
Re: CytoDyn Inc.
Registration Statement on Form S-3 Filed January 15, 2021
File No. 333-252154
Dear Dr. Pourhassan:
January 21, 2021
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
cc: Arian Colachis
Sincerely,
Division of Corporation Finance
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼